Research ArticleResearch Articles
Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma
Ricardo J. Gonzalez, Ragini Kudchadkar, Nikhil G. Rao and Vernon K. Sondak
Ochsner Journal June 2010, 10 (2) 108-116;
Ricardo J. Gonzalez
*Department of Cutaneous Oncology, Moffitt Cancer Center,Tampa, FL
MDRagini Kudchadkar
*Department of Cutaneous Oncology, Moffitt Cancer Center,Tampa, FL
MDNikhil G. Rao
†Departments of Radiation Oncology, Moffitt Cancer Center,Tampa, FL
MDVernon K. Sondak
*Department of Cutaneous Oncology, Moffitt Cancer Center,Tampa, FL
MDArticle Figures & Data
Tables
In this issue
Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma
Ricardo J. Gonzalez, Ragini Kudchadkar, Nikhil G. Rao, Vernon K. Sondak
Ochsner Journal Jun 2010, 10 (2) 108-116;
Jump to section
- Article
- Abstract
- INTRODUCTION
- DEFINING HIGH-RISK MELANOMA
- ADJUVANT RADIOTHERAPY TO THE PRIMARY SITE
- ADJUVANT RADIOTHERAPY TO THE REGIONAL LYMPH NODE BASIN
- RADIOTHERAPY WITH CONCURRENT IFN TO THE REGIONAL LYMPH NODE BASIN
- RADIOTHERAPY DOSE AND FRACTIONATION
- ADJUVANT SYSTEMIC THERAPY TO REDUCE DISEASE RECURRENCE AND DEATH
- FUTURE PROSPECTS FOR MORE EFFECTIVE ADJUVANT THERAPIES
- REFERENCES
- Figures & Data
- References
- Info & Metrics
Cited By...
- No citing articles found.